Pharmaceutical Expenditure and Policies

OECD Health Working Papers
doi 10.1787/5jm0q1f4cdq7-en
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Organisation for Economic Co-Operation and Development (OECD)

Related search

Pharmaceutical Expenditure

Health at a Glance: Asia/Pacific
2012English

Pharmaceutical Expenditure Per Capita, 2015

Health at a Glance: Asia/Pacific
2018English

Pharmaceutical Policies in Australia and New Zealand

Journal of Pharmaceutical Policy and Practice
ToxicologyPharmaceuticsPharmacologyHealth Policy
2015English

Mexico: Experiences With Pro-Poor Expenditure Policies

IMF Working Papers
2002English

Php164 - Pharmaceutical Policies in Portugal – Trends and Impact

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Change in Pharmaceutical Expenditure as a Share of Health Expenditure, 2010 to 2015

Health at a Glance: Asia/Pacific
2018English

Pharmaceutical Cost-Containment Policies and Sustainability: Recent Irish Experience

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

PHP48 Croatian Pharmaceutical Expenditure Before and After Healthcare Reform – Comparison to EU Countries

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

PHP11 Time Trends and Determinants of Pharmaceutical Expenditure in China in 1990-2009

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy